ALNY - Alnylam Pharmaceuticals Non-GAAP EPS of -$0.77 in-line revenue of $439.72M misses by $2.58M
2024-02-15 08:04:42 ET
More on Alnylam Pharmaceuticals
- Alnylam's Huge Opportunity
- Alnylam Pharmaceuticals: R&D Day Reveals Ambitious Plans
- Alnylam Pharmaceuticals Q4 2023 Earnings Preview
- Investors growing more bullish on SMID cap biotech stocks
- Seeking Alpha’s Quant Rating on Alnylam Pharmaceuticals